ACL 移植物类型对合并 ACL-MCL 损伤结局的影响未受内侧副韧带状态显著修饰:法国关节镜学会多中心注册研究
该前瞻性多中心队列研究纳入 2020 年 1 月至 2022 年 6 月法国关节镜学会中心首次 ACL 重建患者,按内侧损伤状态与移植物类型分组,主要结局为 IKDC 主观评分。489 例(67.7%)完成数据纳入分析,非腘绳肌腱移植物与更高 IKDC 评分相关,但 MCL 状态未显著修饰移植物类型与 IKDC 评分的关联。
要点
- 非腘绳肌腱移植物与更高的 IKDC、ACL-RSI 和 SKV 评分相关。
- MCL 状态与移植物类型的交互项无统计学意义,未显著修饰结局关联。
- 孤立 ACL 损伤的 IKDC 评分高于非手术治疗的合并 ACL-MCL 损伤。
核心结论
- 非腘绳肌腱移植物总体与更高的患者报告结局评分相关,但无统计学显著证据表明 MCL 状态修饰移植物类型与 ACL 重建后结局的关联。
研究设计与样本
- 前瞻性多中心注册队列研究,证据等级 3 级,纳入 2020 年 1 月至 2022 年 6 月法国关节镜学会中心首次 ACL 重建患者。
- 722 例符合条件患者中 489 例(67.7%)具有完整结局与协变量数据并纳入主要分析。
- 按内侧损伤状态(孤立 ACL、合并 ACL-MCL 非手术治疗、手术治疗)和移植物类型(腘绳肌腱 vs 非腘绳肌腱)分组。
- 采用基于倾向评分的逆概率加权减少分配偏倚,加权多变量回归模型包含移植物类型、MCL 状态及 Graft × MCL 交互项。
主要发现
- 非腘绳肌腱移植物与更高 IKDC 评分相关(β = 7.89;95% CI,3.45-12.33;P < .001)。
- 孤立 ACL 损伤的 IKDC 评分高于非手术治疗的合并 ACL-MCL 损伤(β = 10.41;95% CI,6.48-14.34;P < .001)。
- Graft × MCL 交互项无统计学意义(手术 MCL:β = -7.02;95% CI,-15.26 至 1.22;P = .095)。
- 非腘绳肌腱移植物还与更高 ACL-RSI(β = 6.15;95% CI,0.02-12.28;P = .049)和 SKV(β = 8.87;95% CI,4.53-13.21;P < .001)相关,Tegner 活动水平无关联。
关键数值与推荐
- 主要结局为国际膝关节文献委员会(IKDC)主观评分,次要结局包括 ACL-RSI、主观膝关节值(SKV)和 Tegner 活动水平。
临床怎么用
- 在合并 ACL-MCL 损伤的 ACL 重建中,移植物类型选择可不因 MCL 状态而改变,非腘绳肌腱移植物与更高患者报告结局评分相关。
- 合并 ACL-MCL 损伤非手术治疗者的 IKDC 评分低于孤立 ACL 损伤者,需关注术后恢复预期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Combined anterior cruciate ligament (ACL) and medial collateral ligament (MCL) injuries are common in pivoting sport athletes and may affect postoperative stability and recovery. Although hamstring autografts are widely used, concerns persist that harvesting the semitendinosus-gracilis complex could impair medial dynamic stabilization in knees with concomitant MCL injury. HYPOTHESIS/PURPOSE: The purpose was to determine whether MCL status modifies the association between ACL graft type and postoperative patient-reported outcomes. It was hypothesized that MCL status would not significantly modify this relationship. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: This prospective multicenter registry study included patients undergoing primary ACL reconstruction between January 2020 and June 2022 in French Arthroscopy Society centers. Patients were categorized by medial injury status (isolated ACL, combined ACL-MCL treated nonoperatively, or operatively) and graft type (hamstring vs nonhamstring). The primary outcome was the International Knee Documentation Committee (IKDC) subjective score. Secondary outcomes included Anterior Cruciate Ligament-Return to Sport after Injury (ACL-RSI), Subjective Knee Value (SKV), and Tegner activity level. Inverse probability weighting based on propensity scores was used to reduce allocation bias. Weighted multivariable regression models included graft type, MCL status, and a Graft × MCL interaction term. RESULTS: Of 722 eligible patients, 489 (67.7%) had complete outcome and covariate data and were included in the primary analysis. Nonhamstring grafts were associated with higher IKDC scores (β = 7.89; 95% CI, 3.45-12.33; P < .001). Isolated ACL injuries showed higher IKDC scores than combined ACL-MCL injuries treated nonoperatively (β = 10.41; 95% CI, 6.48-14.34; P < .001). The Graft × MCL interaction was not statistically significant (operative MCL: β = -7.02; 95% CI, -15.26 to 1.22; P = .095), providing no statistically significant evidence that MCL status modified the association between graft type and IKDC score. Nonhamstring grafts were also associated with higher ACL-RSI (β = 6.15; 95% CI, 0.02-12.28; P = .049) and SKV (β = 8.87; 95% CI, 4.53-13.21; P < .001), whereas no association was observed for Tegner activity level. CONCLUSION: Nonhamstring grafts were associated with higher patient-reported outcome scores overall; however, no statistically significant evidence was found that MCL status modified the association between graft type and outcomes after ACL reconstruction.
引用
- Bouguennec N, Neri T, Carrozzo A, et al. ACL Graft Type Effects on Outcomes Were Not Significantly Modified by Medial Collateral Ligament Status in Combined ACL-MCL Injuries: A Multicenter Registry Study From the French Arthroscopic Society. Am J Sports Med. 2026. PMID: 42801272. doi:10.1177/03635465261487325
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。